Hunterase (recombinant human iduronate-2-sulfatase) / GC Biopharma, CANbridge Pharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hunterase (recombinant human iduronate-2-sulfatase) / GC Biopharma
GC1111, NCT01645189: Safety and Efficacy of Hunterase

Completed
3
6
RoW
Hunterase
Green Cross Corporation
Hunter Syndrome
09/13
09/13
NCT03920540: A Study of GC1111 in Hunter Syndrom Patients

Completed
3
32
RoW
GC1111, Comparator
Green Cross Corporation
Hunter Syndrome
02/22
02/22

Download Options